NCT01612351 2026-03-17Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral SurgeryUNC Lineberger Comprehensive Cancer CenterPhase 2 Completed40 enrolled 20 charts
NCT04024462 2026-02-20A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast CancerHoffmann-La RochePhase 3 Completed200 enrolled 16 charts